Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Weverling

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
The American Review of Respiratory Disease|August 1, 1993
Evaluation of different tests for the serodiagnosis of tuberculosis and the use of likelihood ratios in serologyA Verbon, G J Weverling, S Kuijper, et al.
Archives of Neurology|June 1, 1995
Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosisE S Louwerse, G J Weverling, P M Bossuyt, et al.
HIV Medicine|January 21, 2004
Greater and more rapid depletion of mitochondrial DNA in blood of patients treated with dual (zidovudine+didanosine or zidovudine+zalcitabine) vs. single (zidovudine) nucleoside reverse transcriptase inhibitorsP Reiss, M Casula, A de Ronde, et al.
AIDS (London, England)|October 31, 2001
Kaposi's sarcoma and human herpesvirus 8 infection do not protect HIV-1 infected homosexual men from AIDS dementia complexN Renwick, G J Weverling, T Halaby, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 15, 1996
Predictive value for survival of soluble tumor necrosis factor receptors p55 and p75 during zidovudine-containing treatment in symptomatic human immunodeficiency virus type 1 infectionP H Frissen, G J Weverling, E Endert, et al.
AIDS (London, England)|March 29, 2001
Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infectionN H Dukers, J Goudsmit, J B de Wit, et al.
Antiviral Therapy|December 1, 1996
A comparison of serum HIV-1 RNA levels as measured by two quantitative assays in zidovudine-treated, asymptomatic, HIV-infected individualsG J Weverling, J M Lange, M D de Jong, et al.
Obstetrics and Gynecology|June 1, 1995
The prognosis of cervical cancer associated with pregnancy: a matched cohort studyN van der Vange, G J Weverling, B W Ketting, et al.
The British Journal of Surgery|July 22, 2005
Recurrence after segmental resection for colonic Crohn's diseaseS W Polle, J F M Slors, G J Weverling, et al.
Blood Cells, Molecules & Diseases|October 26, 2005
Increased incidence of cancer in adult Gaucher disease in Western EuropeM de Fost, S Vom Dahl, G J Weverling, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
The American Review of Respiratory Disease|August 1, 1993
Evaluation of different tests for the serodiagnosis of tuberculosis and the use of likelihood ratios in serologyA Verbon, G J Weverling, S Kuijper, et al.
Archives of Neurology|June 1, 1995
Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosisE S Louwerse, G J Weverling, P M Bossuyt, et al.
HIV Medicine|January 21, 2004
Greater and more rapid depletion of mitochondrial DNA in blood of patients treated with dual (zidovudine+didanosine or zidovudine+zalcitabine) vs. single (zidovudine) nucleoside reverse transcriptase inhibitorsP Reiss, M Casula, A de Ronde, et al.
AIDS (London, England)|October 31, 2001
Kaposi's sarcoma and human herpesvirus 8 infection do not protect HIV-1 infected homosexual men from AIDS dementia complexN Renwick, G J Weverling, T Halaby, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 15, 1996
Predictive value for survival of soluble tumor necrosis factor receptors p55 and p75 during zidovudine-containing treatment in symptomatic human immunodeficiency virus type 1 infectionP H Frissen, G J Weverling, E Endert, et al.
AIDS (London, England)|March 29, 2001
Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infectionN H Dukers, J Goudsmit, J B de Wit, et al.
Antiviral Therapy|December 1, 1996
A comparison of serum HIV-1 RNA levels as measured by two quantitative assays in zidovudine-treated, asymptomatic, HIV-infected individualsG J Weverling, J M Lange, M D de Jong, et al.
Obstetrics and Gynecology|June 1, 1995
The prognosis of cervical cancer associated with pregnancy: a matched cohort studyN van der Vange, G J Weverling, B W Ketting, et al.
The British Journal of Surgery|July 22, 2005
Recurrence after segmental resection for colonic Crohn's diseaseS W Polle, J F M Slors, G J Weverling, et al.
Blood Cells, Molecules & Diseases|October 26, 2005
Increased incidence of cancer in adult Gaucher disease in Western EuropeM de Fost, S Vom Dahl, G J Weverling, et al.
Pageof 7